Promising Pharmaceutical Stocks To Consider – April 4th

Eli Lilly and Company, McKesson, Johnson & Johnson, AbbVie, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares in companies that specialize in the research, development, manufacturing, and marketing of drugs and other medical products. These stocks are heavily influenced by regulatory approvals, clinical trial outcomes, and overall market demand, making them a key component within the broader healthcare investment sector. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded down $42.79 during trading hours on Friday, reaching $746.30. 3,074,414 shares of the company were exchanged, compared to its average volume of 3,309,904. Eli Lilly and Company has a 52-week low of $711.40 and a 52-week high of $972.53. The firm has a market cap of $707.62 billion, a price-to-earnings ratio of 63.95, a PEG ratio of 1.40 and a beta of 0.34. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. The stock has a 50 day simple moving average of $849.30 and a 200 day simple moving average of $833.74.

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Shares of NYSE:MCK traded down $26.53 during midday trading on Friday, hitting $690.40. 1,726,001 shares of the company’s stock traded hands, compared to its average volume of 851,459. The firm’s fifty day moving average price is $631.55 and its two-hundred day moving average price is $583.78. The company has a market cap of $86.53 billion, a PE ratio of 31.65, a P/E/G ratio of 1.29 and a beta of 0.49. McKesson has a twelve month low of $464.42 and a twelve month high of $758.64.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE JNJ traded down $5.17 during midday trading on Friday, reaching $154.65. 7,522,241 shares of the company’s stock were exchanged, compared to its average volume of 7,757,426. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $169.99. The business’s fifty day moving average price is $159.63 and its two-hundred day moving average price is $156.01. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11. The stock has a market capitalization of $372.68 billion, a PE ratio of 23.30, a price-to-earnings-growth ratio of 2.56 and a beta of 0.47.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

NYSE:ABBV traded down $9.91 during mid-day trading on Friday, reaching $191.73. The stock had a trading volume of 5,977,889 shares, compared to its average volume of 5,770,760. AbbVie has a 1-year low of $153.58 and a 1-year high of $218.66. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. The company has a market capitalization of $339.16 billion, a price-to-earnings ratio of 79.96, a price-to-earnings-growth ratio of 1.62 and a beta of 0.61. The stock’s 50 day simple moving average is $200.28 and its two-hundred day simple moving average is $189.30.

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Shares of NYSE:PFE traded down $1.08 during trading on Friday, hitting $23.21. 45,816,333 shares of the company traded hands, compared to its average volume of 39,341,189. Pfizer has a one year low of $23.13 and a one year high of $31.54. The company has a quick ratio of 0.73, a current ratio of 1.00 and a debt-to-equity ratio of 0.63. The business’s fifty day moving average is $25.93 and its 200-day moving average is $26.81. The stock has a market capitalization of $131.62 billion, a price-to-earnings ratio of 16.48, a PEG ratio of 0.64 and a beta of 0.61.